Cutler Group LP Pacific Biosciences Of California, Inc. Call Options Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	BUY	$5.97 - $10.36 $3,582 - $6,216	600 Added 150.0%	1,000 $2,000
Q2 2023 Jul 18, 2023	SELL	$9.97 - $14.05 $50,847 - $71,655	-5,100 Reduced 92.73%	400 $3,000
Q1 2023 May 01, 2023	SELL	$7.94 - $12.02 $11,116 - $16,828	-1,400 Reduced 20.29%	5,500 $16,000
Q4 2022 Feb 07, 2023	SELL	$5.67 - $11.2 $256,851 - $507,359	-45,300 Reduced 86.78%	6,900 $5,000
Q3 2022 Oct 25, 2022	SELL	$3.93 - $8.57 $104,931 - $228,819	-26,700 Reduced 33.84%	52,200 $13,000
Q2 2022 Aug 04, 2022	BUY	$4.02 - $10.43 $117,383 - $304,556	29,200 Added 58.75%	78,900 $12,000
Q1 2022 Apr 14, 2022	BUY	$8.43 - $20.9 $314,439 - $779,570	37,300 Added 300.81%	49,700 $10,000
Q4 2021 Jan 18, 2022	SELL	$19.26 - $30.08 $552,762 - $863,296	-28,700 Reduced 69.83%	12,400 $8,000
Q3 2021 Oct 26, 2021	BUY	$24.86 - $35.02 $524,546 - $738,922	21,100 Added 105.5%	41,100 $21,000
Q2 2021 Jul 19, 2021	SELL	$22.3 - $36.02 $963,360 - $1.56 Million	-43,200 Reduced 68.35%	20,000 $113,000
Q1 2021 Apr 26, 2021	BUY	$26.38 - $51.15 $1.09 Million - $2.11 Million	41,200 Added 187.27%	63,200 $80,000
Q4 2020 Jan 21, 2021	BUY	$10.5 - $28.5 $231,000 - $627,000	22,000 New	22,000 $56,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.